Randomised phase II evaluation of irinotecan plus high-dose 5-fluorouracil and leucovorin (ILF) vs 5-fluorouracil, leucovorin, and etoposide (ELF) in untreated metastatic gastric cancer

An open-label randomised comparison of efficacy and tolerability of irinotecan plus high-dose 5-fluorouracil (5-FU) and leucovorin (LV) (ILF) with etoposide plus 5-FU/LV (ELF) in patients with untreated metastatic or locally advanced gastric cancer. One cycle of ILF comprised six once-weekly infusio...

Descripción completa

Detalles Bibliográficos
Autores principales: Moehler, M, Eimermacher, A, Siebler, J, Höhler, T, Wein, A, Menges, M, Flieger, D, Junginger, T, Geer, T, Gracien, E, Galle, P R, Heike, M
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2005
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361806/
https://www.ncbi.nlm.nih.gov/pubmed/15942629
http://dx.doi.org/10.1038/sj.bjc.6602649

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361806/
https://www.ncbi.nlm.nih.gov/pubmed/15942629
http://dx.doi.org/10.1038/sj.bjc.6602649

Ejemplares similares